Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.

A Blood Test Shows MS Worsening 1 to 2 Years Before It Happens Nov. 6, 2023 — Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched controls who hadn't.

Competing in a marathon could be considered quite the task for some, but not for one Amyotrophic Lateral Sclerosis (ALS) ...

Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.